Short Interest in Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Decreases By 50.0%

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 1,000 shares, a drop of 50.0% from the February 13th total of 2,000 shares. Based on an average daily volume of 600 shares, the days-to-cover ratio is currently 1.7 days.

Hikma Pharmaceuticals Trading Down 0.1 %

OTCMKTS HKMPY traded down $0.07 during trading hours on Friday, hitting $52.33. 2,777 shares of the company were exchanged, compared to its average volume of 922. The stock has a 50-day moving average price of $54.65 and a 200 day moving average price of $51.65. Hikma Pharmaceuticals has a 52 week low of $46.16 and a 52 week high of $59.26.

Hikma Pharmaceuticals Increases Dividend

The business also recently declared a dividend, which will be paid on Monday, May 12th. Stockholders of record on Friday, March 21st will be issued a $0.94 dividend. The ex-dividend date of this dividend is Friday, March 21st. This is an increase from Hikma Pharmaceuticals’s previous dividend of $0.62. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is currently 10.34%.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.